XML 51 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of Estimated Useful Lives

Depreciation is calculated using the following estimated useful lives:

 

Classification   Years
Machinery and Equipment   5-10
Furniture and Fixtures   5-10
Computer Hardware   5-10
Leasehold Improvements   10-20
Schedule of Fair Value On a Recurring Basis Assets and Liability

The following tables provides a summary of the relevant assets and liabilities that are measured at fair value on recurring basis:

 

Fair Value Measurements as of

December 31, 2023

 

   Total   (Level 1)   (Level 2)    (Level 3) 
Liabilities:                    
Warrant liabilities  $8,225   $—   $—   $8,225 
Derivative liabilities  $—   $—   $—   $— 
Total Liabilities  $8,225   $—   $—   $8,225 

 

Fair Value Measurements as of

December 31, 2022

 

   Total   (Level 1)   (Level 2)   (Level 3) 
Liabilities:                    
Warrant liabilities  $2,234,384   $—   $—   $2,234,384 
Derivative liabilities  $1,735,700   $—   $—   $1,735,700 
Total Liabilities  $3,970,084   $—   $—   $3,970,084 
Schedule of Unobservable Inputs for Level 3 Assets and Liabilities

The following table shows the valuation methodology and unobservable inputs for Level 3 assets and liabilities measured at fair value on recurring basis as of December 31, 2023 and December 31, 2022:

 

   Fair Value As of   Fair Value   Valuation  Unobservable
   December 31, 2023   December 31, 2022   Methodology  Inputs
Warrant liabilities  $8,225   $2,234,384   Monte Carlo model  Project simulated cash flows
Derivative liabilities  $—   $1,735,700   Monte Carlo model  Project simulated cash flows
Schedule of Dilutive Common Stock Equivalents

The Company had the following potentially dilutive common stock equivalents at December 31, 2023 and 2022:

  

   2023   2022 
         
Convertible Series A Preferred Stock   —    1,013,270 
Convertible Series Seed Preferred Stock   —    230,954 
Options   1,319,394    1,319,394 
Pre-Funded Warrants for Convertible Series A Preferred Stock   —    289,779 
Warrants   1,822,358    365,962 
Convertible Bridge Debt   —    376,653 
Totals   3,141,752    3,596,012 
Schedule of Basic and Diluted Net Loss Per Share

The following table shows the calculation of the basic and diluted net loss per share and the effect of preferred stock dividends.

  

   2023   2022 
   For the Years Ended December 31, 
   2023   2022 
Numerator          
Net loss  $(14,626,683)   (4,780,061)
Preferred stock dividends   —    (764,893)
 Net income (loss) available to common stockholders    (14,626,683)   (5,544,954)
Denominator          
Weighted-average shares of common stock outstanding - basic and diluted   3,252,328    2,003,322 
Basic and diluted net loss per share  $(4.50)  $(2.77)
Schedule of Disaggregation of Revenue

The following table disaggregates the Company’s revenue based on the customer’s location by state for the years ended December 31:

  

   2023      2022 
California  $601,235   Wisconsin  $670,245 
Ohio   407,632   Ohio   500,260 
Wisconsin   292,601   California   408,645 
Florida   186,840   Florida   231,480 
Massachusetts   127,300   Missouri   174,980 
All other states   844,441   All other states   699,125 
   $2,460,049      $2,684,735 
Schedule of Customers Accounted Revenues

  

       Percentage of       Percentage of
   2023   Sales  2022   Sales
               
Hospital A  $452,680   18%  $355,613   13%
Hospital B   382,082   16%   484,900   18%
Hospital C   274,581   11%   554,325   21%
   $1,109,343   45%  $1,394,838   52%